Contact
Please use this form to send email to PR contact of this press release:
FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib)
TO:
Please use this form to send email to PR contact of this press release:
FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib)
TO: